Are third-generation cephalosporins still an option for empirical antibiotic therapy in critically ill trauma patients with early ventilator or hospital-acquired pneumonia?
- 1 April 2021
- journal article
- letter
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 40 (2) , 100833
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Piperacillin-tazobactam should be preferred to third-generation cephalosporins to treat wild-type inducible AmpC-producing Enterobacterales in critically ill patients with hospital or ventilator-acquired pneumoniaJournal of Critical Care, 2020
- Surgical Antibiotic Prophylaxis and Risk for Postoperative Antibiotic-Resistant InfectionsJournal of the American College of Surgeons, 2017
- Systematic Review of the Literature and Evidence-Based Recommendations for Antibiotic Prophylaxis in Trauma: Results from an Italian Consensus of ExpertsPLOS ONE, 2014
- Pathogens in Early-Onset and Late-Onset Intensive Care Unit–Acquired PneumoniaInfection Control & Hospital Epidemiology, 2007